These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38586917)

  • 1. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against
    Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H
    J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer.
    Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H
    Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
    Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
    Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085.
    Hui B; Zhou C; Xu Y; Wang R; Dong Y; Zhou Y; Ding J; Zhang X; Xu J; Gu Y
    J Nanobiotechnology; 2024 Feb; 22(1):62. PubMed ID: 38360615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remotely Controllable Supramolecular Nanomedicine for Drug-Resistant Colorectal Cancer Therapy Caused by Fusobacterium nucleatum.
    Yan X; Xin Y; Yu Y; Li X; Li B; Elsabahy M; Zhang J; Ma F; Gao H
    Small Methods; 2024 Mar; 8(3):e2301309. PubMed ID: 38018349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
    Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
    Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.
    LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S
    Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Targeting Nanoassembly for Enhanced Colorectal Cancer Therapy by Eliminating Intratumoral
    Li X; Ma Y; Xin Y; Ma F; Gao H
    ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916659
    [No Abstract]   [Full Text] [Related]  

  • 10. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
    Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
    Acta Biomater; 2024 Jul; 183():278-291. PubMed ID: 38838905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.
    Ning Q; Liu YF; Ye PJ; Gao P; Li ZP; Tang SY; He DX; Tang SS; Wei H; Yu CY
    ACS Appl Mater Interfaces; 2019 Mar; 11(11):10578-10588. PubMed ID: 30802029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
    Li M; Liang Z; Sun X; Gong T; Zhang Z
    PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway.
    Su M; Qin B; Liu F; Chen Y; Zhang R
    Drug Des Devel Ther; 2017; 11():3333-3341. PubMed ID: 29200829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
    Luo D; Zhang Y; Yang S; Tian X; Lv Y; Guo Z; Liu X; Han G; Liu S; Wang W; Cui S; Qu X; Wan S
    Eur J Med Chem; 2021 Dec; 225():113775. PubMed ID: 34411894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy.
    Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y
    J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
    Liu ZY; Tang ML; Ning JF; Hao YP; Zhou L; Sun X
    Eur J Med Chem; 2020 May; 193():112194. PubMed ID: 32203786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Delivery Janus-Prodrug for Precise Immuno-Chemotherapy of Colitis-Associated Colorectal Cancer.
    Zhang Q; Li S; Bai L; Yu D; Li H; Tong R
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):297-306. PubMed ID: 34958191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermosensitive methyl-cellulose-based injectable hydrogel carrying oxaliplatin for the treatment of peritoneal metastasis in colorectal cancer.
    Yang J; Wei Y; Gao L; Li Z; Yang X
    J Mater Chem B; 2024 May; 12(21):5171-5180. PubMed ID: 38687592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.